Centre of Evidence Based Dermatology
  • Print

Home Interventions and Light therapy for the treatment of vitiligo

 

The HI-Light Vitiligo Trial is a clinical trial involving 517 participants aged 5 years and over with vitiligo. The purpose of this study is to test the effectiveness of home-based light therapy using hand-held units and topical steroid for the treatment of vitiligo.

The study is being led by Dr Jonathan Batchelor and Professor Kim Thomas from the Centre of Evidence Based Dermatology at The University of Nottingham, and is being co-ordinated from the Nottingham Clinical Trials Unit.

HiLight-Logo-main-rct

We hope to be able to publish the results of the trial in the near future.

For other enquiries, please email hilight@nottingham.ac.uk

 

Key Facts

1. What is vitiligo?

Vitiligo is a skin condition that causes white patches on the skin. It affects around 0.5%-1.0% of the population worldwide, both children and adults.

 
2. Who took part in the trial?

People with a few relatively small patches of vitiligo, and at least one patch that has appeared or has enlarged in the last 12 months, were invited to participate in the trial. In total, 517 adults and children (5+ years of age) took part across the UK.

 
3. What treatments did you test?

Steroid ointment (applied to the skin) and home-based light therapy were tested in this study. These two treatments were used either by themselves or in combination, in order to see if combination treatment works better than either treatment alone.

In order to prevent anyone from guessing a participant’s treatment, dummy UVB devices and placebo steroid ointment were used.

 
4. What are the study results?
The results of the trial will be added to this webpage once they have been published in a medical journal.
 
 
 

Disclaimer: This is an independent trial that is being funded by the National Institute for Health Research Health Technology Assessment Programme (Application Reference 12/24/02). The views expressed on this website are those of the author(s) and not necessarily those of the NIHR. The study has been developed with the help and support of the UK Dermatology Clinical Trials Network (UK DCTN). Based at the University of Nottingham, the UK DCTN is a collaborative group of over 700 dermatologists, nurses, primary care staff, health care researchers and patients/carers. The aim of the Network is simple – to develop independent, high quality randomised controlled clinical trials of interventions for the treatment or prevention of skin disease. For further information please see the UK DCTN website - www.ukdctn.org.

 

Centre of Evidence Based Dermatology

The University of Nottingham
King's Meadow Campus
Lenton Lane
Nottingham, NG7 2NR


telephone: +44 (0) 115 823 1048
email:cebd@nottingham.ac.uk